|
NCT00002387
|
Not Applicable
|
The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz
|
N/A
|
|
NCT00002388
|
Phase 1
|
A Study of 1592U89 in HIV-Infected Patients
|
N/A
|
|
NCT00002389
|
Phase 3
|
The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
|
N/A
|
|
NCT00002390
|
Phase 2
|
A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients
|
N/A
|
|
NCT00002391
|
Phase 3
|
The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs
|
N/A
|
|
NCT00002392
|
Not Applicable
|
A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART
|
N/A
|
|
NCT00002393
|
Phase 3
|
A Study of Indinavir Taken With or Without DMP 266
|
N/A
|
|
NCT00002394
|
Not Applicable
|
Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
|
N/A
|
|
NCT00002395
|
Phase 2
|
Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)
|
N/A
|
|
NCT00002396
|
Phase 1
|
The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients
|
Active, not recruiting
|
|
NCT00002397
|
Phase 3
|
A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease
|
N/A
|
|
NCT00002398
|
Not Applicable
|
Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
|
N/A
|
|
NCT00002399
|
Phase 2
|
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
|
N/A
|
|
NCT00002400
|
Not Applicable
|
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
|
N/A
|
|
NCT00002401
|
Not Applicable
|
A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
|
N/A
|
|
NCT00002402
|
Phase 1
|
A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines
|
N/A
|
|
NCT00002403
|
Phase 1
|
Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients
|
N/A
|
|
NCT00002404
|
Not Applicable
|
The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients
|
N/A
|
|
NCT00002405
|
Not Applicable
|
A Study of Amprenavir in HIV-Infected Patients
|
N/A
|
|
NCT00002406
|
Phase 3
|
A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients
|
N/A
|